We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The role of mutations in epigenetic regulators in myeloid malignancies.
- Authors
Shih, Alan H; Abdel-Wahab, Omar; Patel, Jay P; Levine, Ross L
- Abstract
Recent genomic studies have identified novel recurrent somatic mutations in patients with myeloid malignancies, including myeloproliferative neoplasms (MPNs), myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML). In some cases these mutations occur in genes with known roles in regulating chromatin and/or methylation states in haematopoietic progenitors, and in other cases genetic and functional studies have elucidated a role for specific mutations in altering epigenetic patterning in myeloid malignancies. In this Review we discuss recent genetic and functional data implicating mutations in epigenetic modifiers, including tet methylcytosine dioxygenase 2 (TET2), isocitrate dehydrogenase 1 (IDH1), IDH2, additional sex combs-like 1 (ASXL1), enhancer of zeste homologue 2 (EZH2) and DNA methyltransferase 3A (DNMT3A), in the pathogenesis of MPN, MDS and AML, and discuss how this knowledge is leading to novel clinical, biological and therapeutic insights.
- Publication
Nature reviews. Cancer, 2012, Vol 12, Issue 9, p599
- ISSN
1474-1768
- Publication type
Journal Article
- DOI
10.1038/nrc3343